J. Over

发表

H. Schuitemaker, A. B. van 't Wout, M. Kleijn, 2007, Biologicals : journal of the International Association of Biological Standardization.

Virus validation of pH 4-treated human immunoglobulin products produced by the Cohn fractionation process.

H. Schuitemaker, F. V. van Engelenburg, J. Over, 1998, Biologicals : journal of the International Association of Biological Standardization.

Inactivation of human immunodeficiency virus by gamma radiation and its effect on plasma and coagulation factors

M. Tersmette, J. Over, H. Hiemstra, 1991, Transfusion.

Preservation and Storage of Human Blood Plasma Proteins

J. Loos, J. Over, 1990 .

Human platelet 6-phosphofructokinase. Relation between inhibition by Mg-ATP2-and cooperativity towards fructose 6-phosphate and investigations on the formation of a ternary complex.

J. Sixma, J. Akkerman, G. Staal, 1975, Biochimica et biophysica acta.

Methodology of the one-stage assay of Factor VIII (VIII:C).

J. Over, 2009, Scandinavian journal of haematology. Supplementum.

Contributions to the Optimal Use of Human Blood

P. J. Hoek, J. Over, H. Brummelhuis, 1974, Vox sanguinis.

Virus safety of plasma products using 20 nm instead of 15 nm filtration as virus removing step.

L. Dekker, A. Kempers, A. Koenderman, 2012, Biologicals : journal of the International Association of Biological Standardization.

Survival of 125iodine-labeled Factor VIII in normals and patients with classic hemophilia. Observations on the heterogeneity of human Factor VIII.

J. Sixma, B. Bouma, J. Over, 1978, The Journal of clinical investigation.

Virus Validation of PH 4-treated Human Immunoglobulin Produced by the Cohn Fractionation Process

H. Schuitemaker, J. Over, F. A. C. Engelenburg, 1998 .

Viral safety of human plasma-derived medicinal products: impact of regulation requirements.

K. J. Velthove, M. Janssen, J. Over, 2013, Transfusion medicine reviews.

Heterogeneity of human factor VIII. I. Characterization of factor VIII present in the supernatant of cryoprecipitate.

J. Sixma, J. V. van Mourik, I. Bakker-Woudenberg, 1978, The Journal of laboratory and clinical medicine.

Heterogeneity of human factor VIII. II. Characterization of forms of factor VIII binding to platelets in the presence of ristocetin.

J. Sixma, J. Over, N. Beeser-Visser, 1978, The Journal of laboratory and clinical medicine.

Biosynthesis and composition of 3 -sterols in some holothurians.

P. Voogt, J. Over, 1973, Comparative biochemistry and physiology. B, Comparative biochemistry.

Large-scale purification of factor VIII by affinity chromatography: optimization of process parameters.

E. de Jonge, A. Bantjes, T. Beugeling, 1990, Journal of chromatography.

Evaluation of Platelet Tests for Measurement of Cell Integrity

J. Sixma, J. Akkerman, J. Lips, 1978, Thrombosis and Haemostasis.

Affinity Purification of Plasma Proteins: Characterization of Six Affinity Matrices and their Application for the Isolation of Human Factor VIII

B. König, J. Over, A. Faber, 1989, Thrombosis and Haemostasis.

Quality control of the one-stage Factor VIII (VIII:C) assay in the coagulation laboratory.

J. Over, 2009, Scandinavian journal of haematology. Supplementum.

Thermal Inactivation of Human Immunodeficiency Virus in Lyophilised Blood Products Evaluated by ID50 Titrations

F. Miedema, H. Huisman, J. Over, 1986, Vox sanguinis.

A probabilistic model for analyzing viral risks of plasma‐derived medicinal products

Mart P Janssen, Jan Over, Cees L van der Poel, 2007, Transfusion.

The effect of storage of whole blood on the association of factor VIII-related antigen and factor VIII-coagulant antigen.

J. V. van Mourik, J. Hellings, J. Over, 2009, Scandinavian journal of haematology.

A Phase I/IIa Study with Succinylated Human Serum Albumin (Suc-HSA), a candidate HIV-1 Fusion Inhibitor

J. Proost, F. Wit, D. Meijer, 2007, Antiviral Therapy.

Heterogeneity of human factor VIII. III. Transitions between forms of factor VIII present in cryoprecipitate and in cryosupernatant plasma.

J. Sixma, B. Bouma, P. Bolhuis, 1980, The Journal of laboratory and clinical medicine.

Survival of iodine-125-labeled factor VIII in patients with von Willebrand's disease.

J. Sixma, B. Bouma, P. Bolhuis, 1981, The Journal of laboratory and clinical medicine.

Predominance of normal low molecular weight forms of factor VIII in "variant" von Willebrand's disease.

J. Sixma, I. Peake, B. Bouma, 1978, Thrombosis research.

Assay of F. VIII-Related Antigen in a Variant of von Willebrand’s Disease.

J. Sixma, J. Over, H. A. Vlooswijk, 1977, Thrombosis and Haemostasis.

Virus inactivation by addition of neutralizing antibodies.

J. Over, H. Brummelhuis, 1989, Current studies in hematology and blood transfusion.

Contributions to the Optimal Use of Human Blood

J. Over, Brummelhuis Hg, G. Ateş, 1974, Vox sanguinis.